ASSOCIAÇÃO DE PROBIÓTICOS EM TRATAMENTOS DE MULHERES COM RECORRENTES INFECÇÕES DO TRATO URINÁRIO

Abstract

Recurrent urinary tract infections are determined by diagnoses of three incidences over a period of six months, this is the average time and quantity that some patients reported suffering from; a topic of public health discussion from a medical point of view around the world. Causing symptoms such as pain, burning, discomfort when urinating, hematuria, depending on whether the case progresses to hospitalization, it largely harms women, as it is caused by the installation of the bacteria Escherichia coli along with low immunity, inappropriate behavioral habits such as lack of intimate hygiene, reproductive age, biological individualities, becoming a UTI. This disease is treated with the use of antibiotics, for example: nitrofurantoin, ciprofloxacin, etc.; In specific cases where they occur with recurrence, doctors are observing the need to use a combination of one or more antibiotics, higher dosages and prolongation of treatments, and noting the emergence of other problems such as bacterial resistance, whether due to self-medication or inappropriate use of medications , representing a failure in treatment and an obstacle to healing and the case becoming increasingly worse. Probiotic strains (Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14) have been emerging as a way to complement antibiotic treatment in recurrent cases of UTIs, acting as prophylactic agents and considerably reducing recurrence, as they act to restore the intestinal and vaginal microbiota, increasing the bioavailability time of the antibiotic, modulating the immunological response, reducing these side effects, such as: dysbiosis, colic; and with this helping to maintain balance, it must be done with the supervision of a trained health professional, the treatment of this patient must be evaluated with the aim of resolving the infection, restoring her quality of life and wellbeing in the long term.